鐢�(ch菐n)鍝佷粙绱癸細
Esco Isoclean 闅旈洟寮忓埗钘ユ搷浣滃畨鍏ㄦ煖锛堣矤(f霉)澹撳瀷锛�, 鎻愪緵鍗遍毆鍝�銆佺劇鑿岃棩鍝侀厤鍒朵竴鍊嬬鍚圲SP 797 瑕�(gu墨)鏍肩殑瀹夊叏鍜屾綌鍑堢挵(hu谩n)澧�銆�
鐩告瘮浜庨枊鏀惧紡鐨勬綌鍑堢┖姘ｈō(sh猫)鍌�锛屽瓒呮綌鍑堝伐浣滆嚭鍜屼簩绱氱敓鐗╁畨鍏ㄦ煖锛岄殧闆㈢郴绲�(t菕ng)鎻愪緵鏇村姞鍎�(y艒u)瓒婄殑闅旈洟鎬ц兘銆傛澶�锛孶SP 797妯�(bi膩o)婧�(zh菙n)婧�(zh菙n)鍓囨寚瀹氶殧闆㈠櫒鏇撮仼鍚堢敤浜庝竴鍊嬭純灏戝彈鍒板毚(y谩n)鍘茬挵(hu谩n)澧冩帶鍒剁殑鍦板崁(q奴)銆�
閬╃敤浜庣劇鑿屾妧琛�(sh霉)鍩硅〒(x霉n)锛屾搷浣滈亷绋嬮璀�锛岄亷鏈熻ō(sh猫)缃拰缍(h霉)鐢�(ch菐n)鍝佽唱(zh矛)閲忕殑涓�閮ㄥ垎锛岄殧闆㈠櫒绯荤当(t菕ng)鏄竴鍊嬫湁鏁堢殑瑙ｆ焙鏂规锛岀壒鍒ユ槸浣庨噺鐨勫埗钘ユ搷浣�銆傚湪娓涘皯缍�(j墨ng)鐕熷拰瑁濅慨鎴愭湰鐨勫悓鏅�锛屽叾闅旈洟鍣ㄥ崰鐢ㄦ洿灏戠殑绌洪枔锛屼互鍙婃槗浜庣董璀�(h霉)銆�
Isoclean 闅旈洟寮忓埗钘ユ搷浣滃畨鍏ㄦ煖锛堣矤(f霉)澹撳瀷锛夐仼鐢ㄤ簬娑夊強鍗遍毆鏉愭枡锛屾姉鑵槫锛屾垨绱�(x矛)鑳炴瘨鎬х殑鍒惰棩鎳�(y墨ng)鐢�銆傚伐浣滃崁(q奴)鍜岄�氶亷浜ゆ彌鍗�(q奴)閮芥槸鍦ㄨ矤(f霉)澹撳姏鐨勬儏娉佷笅閬�(y霉n)浣�锛屽湪灞忛殰闅旈洟绯荤当(t菕ng)鏁呴殰鐨勬儏娉佷笅纰轰繚瀹夊叏鏌滃収(n猫i)鏄劇鑿岀殑锛屼互淇濊(h霉)鎿嶄綔鑰呯殑瀹夊叏銆�
* United States Pharmacopoeia (USP), Chapter 797(1), enacted January 1, 2004, presents the first enforceable standards for sterile compounding. Following years of patient safety recommendations and professional guidelines, the intent of USP 797 is to set forth the procedural and practical requirements for safe compounding of sterile preparations. The Chapter's requirements are applicable in all practice settings where sterile preparations are compounded.
鏍稿績鍎�(y艒u)鍕細
- ISO 娼斿噲搴︽(bi膩o)婧�(zh菙n)3绱氬伐浣滃崁(q奴)
- 楂樼礆鎿嶄綔鑰呬繚璀�(h霉)
- 蹇�熷惞鎺冩檪闁�
- 姗�(j墨)鍕曢珮搴︽敮鏋�
- 绗﹀悎USP 797 瑕�(gu墨)鏍�
鍦板潃锛氳タ瀹夊競澶櫧鍗楄矾5铏熺传钖囧皻灞よタ涓�妯撲竴鍠厓1407瀹CP鍌欙細